Contact

About this website

BELGIAN BIOSAFETY SERVER

[Home Page] [Previous Menu] [Search]

SARS Coronavirus
Useful links
(Author: P. Herman) (Last revised: October 24, 2008 )

General information about SARS - Guidelines - References

General information about SARS from official websites

Belgium

Public Health

Publication of the Belgian ad hoc workgroup on SARS-Coronavirus

Herman P, Verlinden Y, Breyer D, Van Cleemput E, Brochier B, Sneyers M, Snacken P, Hermans P, Kerkhofs P, Liesnard C, Rombaut B, Van Ranst M, Van der Groen G, Goubau P, Moens W. Biosafety Risk Assessment of the Severe Acute Respiratory Syndrome (SARS) Coronavirus and Containment Measures for the Diagnostic and Research Laboratories. Applied Biosafety, 2004; 9(3):128-142.

International

WHO

Consensus document on the epidemiology of the SARS ( 800 kb)
Summary of the discussion and recommendations of the SARS laboratory workshop, 22 october 2003 ( 88 kb)
WHO post-outbreak biosafety guidelines for handling of SARS-CoV specimens and cultures
A very comprehensive WHO website for the western pacific region with available updates, guidelines, press releases, reports, presentations, laboratory network informations and FAQ.
The Role of Animals in the Transmission of SARS, Dr Hume Field, june 17 2003, Global conference on SARS, Kuala Lumpur, Malaysia (link)

USA

Center for Disease Control, Atlanta

Canada

Health Canada/Santé Canada

Australia

Australian government, Department of health and ageing

European Commission

SARS EC website

United Kingdom

Health Protection Agency

Germany

France

Ministère de la santé, de la famille et des personnes handicapées

The Netherlands

Italy

Epicentro

Taiwan

Center for Disease Control, Dept of Health

Hong-Kong

Hong-Kong Government

Guidelines

WHO biosafety guidelines for handling of SARS specimens. World Health Organisation, 2003 (link)
Biosafety Advisory - Severe Acute respiratory Syndrome: Interim Guidelines. Health Canada, 2003 (link)
"Conduite à tenir pour la prise en charge des personnes présentant un syndrome ou une suspicion de syndrome repiratoire aigu sévère et des personnes contacts". France, Ministère de la Santé, de la Famille et des Personnes handicapées, 2003 (link)
"Conceptprotocol SARS". Landelijke Coördinatiestructuur Infectieziektebestrijding, The Nederlands, 2003 (link)

References

Ng SK. Possible role of an animal vector in the SARS outbreak at Amoy Gardens. Lancet, 2003; 362 : 570-572.
Booth CM, Matukas LM, Tomlinson GA et al. Clinical features and shor-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA, 2003; 289 : 2801-2809.
Ksiazek TG, Erdman D, Goldsmith CS et al. A novel coronavirus associated with SARS. N Engl J Med, 2003; 348:1953-1966.
Drosten C, Günther S, Preiser W et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med, 2003; 348:1967-1976.
Peiris JSM, Lai ST, Poon LLM et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet, 2003; 361:1319-1325
Guan Y, Zheng BJ, He YQ et al. Isolation and characterization of viruses related to the SARS Coronavirus from animals in Souhtern China. Science, 2003; 302 (5643) : 276-278
Holmes KV. SARS-Associated Coronavirus. N Engl J Med, 2003; 348:1948-1951.
Marra MA, Jones SJM, Astell CR, et al. The genome Sequence of the SARS-Associated Coronavirus. Science, 2003; 300 : 1399-1404.
Hofmann H, Pöhlmann S. Cellular entry of the SARS coronavirus. Trends in Microbiology, 2004; 12(10): 466-472.
Tu C, Crameri G, Kong X et al. Antibodies to SARS Coronavirus in Civets. Emerging Infectious Diseases, 2004; 10(12): 2244-2248.

SARS-Coronavirus stability, replication in cell lines and inactivation

First data on stability and resistance of SARS coronavirus compiled by members of WHO laboratory network (link)
Kariwa H, Fujii N, Takashima I. Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions, and chemical reagents. Jpn J Vet Res, 2004; 52(3): 105-112.
Yunoki M, Urayama T, Yamamoto I et al. Heat sensitivity of a SARS-associated coronavirus introduced into plasma products. Vox Sang, 2004; 87(4): 302-303.
Darnell ME, Subbarao K, Feinstone SM, Taylor DR. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. J Virol Methods, 2004; 121(1): 85-91.
Wang Y, Wu X, Wang Y et al. Low stability of nucleocapsid protein in SARS virus. Biochemistry, 2004; 31 (43): 11103-11108.
Rabenau HF, Cinatl J, Morgenstern B et al. Stability and inactivation of SARS coronavirus. Med Microbiol Immunol (Berl.), 2005; 194(1-2): 1-6.
Wang XW, Li JS, Jin M et al. Study on the resistance of severe acute respiratory syndrome-associated coronavirus. J Virol Methods, 2005; 126(1-2): 171-177.
Kaye M. SARS-associated coronavirus replication in cell lines. Emerg Infect Dis, 2006; 12(1): 128-133.
Han J, Chen L, Duan SM, Yang QX, Yang M, Gao C, Zhang BY, He H, Dong XP. Efficient and quick inactivation of SARS coronavirus and other microbes exposed to the surfaces of some metal catalysts. Biomed Environ Sci. 2005; 18(3):176-80.
Chen C, Zhang XJ, Wang Y, Zhu LX, Liu J. Waste water disinfection during SARS epidemic for microbiological and toxicological control. Biomed Environ Sci, 2006; 19(3):173-178.
Kariwa H, Fujii N, Takashima I. Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents. Dermatology. 2006; 212 Suppl 1:119-23.
Verschueren KH, Pumpor K, Anemüller S, Chen S, Mesters JR, Hilgenfeld R. A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters. Chem Biol, 2008; 15(6):597-606